IL17A and neoplasm: Conversely, γδ T cells producing IL-17 have been suggested to negatively impact the progression of colon (43), gallbladder (44), and breast cancer (45), either by suppressing immune cell functions, promoting immune cell pro-tumor activity, or by inducing angiogenesis.